Report #2849096

Received Jul 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
CHIK	CHIKUNGUNYA LIVE (IXCHIQ)	VALNEVA USA, INC.	UNK	24I005	—

Symptoms (10)

ArthralgiaDiarrhoeaDyspepsiaFatigueHeadacheMyalgiaNauseaPruritusPyrexiaVision blurred

Symptom narrative

Fatigue; Joint pain; Muscle pain; Fever; Nausea; Headache; Diarrhea; Indigestion; Pruritis; Blurry vision; The following information was received from a consumer on 24 Jun 2025. A 29-year-old male vaccinee received one dose of IXCHIQ (prevention of disease caused by chikungunya virus (CHIKV)), batch number 24I005) on an unknown date. Four days after vaccination he developed fatigue, joint and muscle pain, fever, nausea, headache, diarrhea, indigestion, pruritis and blurry vision, which lasted greater than two weeks.; Sender's Comments: Company's medical assessment: The causality was assessed as possibly related for all reported events, as time to onset is plausible (4 days past vaccination) indicative of a systemic vaccination reaction, and as Fatigue, joint and muscle pain, fever, nausea and headache are listed for IXCHIQ according to RSI. No further details were provided and no confounding factors were reported.

Medical history

Comments: None